🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase I/II study using the combination of twice weekly ixazomib p...
Status
Active Not Recruiting
Location
Dana Farber Cancer Institute
Start Date
2019-09-18
Trial ID
NCT04094961
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of ixazomi...
Status
Unknown
Location
PekingUMCH
Start Date
2021-07-26
Trial ID
NCT04989140
Treatments Being Tested
This randomized phase I/II trial studies the side effects and best dose of ...
Status
Unknown
Location
Anchorage Associates in Radiation Medicine
Start Date
2014-02
Trial ID
NCT02004275
Treatments Being Tested
This is a multicenter, randomized, open-label, Phase 3 study comparing the ...
Status
Completed
Location
Local Institution - 109
Start Date
2019-04-16
Trial ID
NCT03651128
This phase I/II trial studies the side effects and best dose of clarithromy...
Status
Active Not Recruiting
Location
University of California San Diego
Start Date
2015-10
Trial ID
NCT02542657
Treatments Being Tested
The purpose of this study is assess safety, safest dose, and effectiveness ...
Status
Active Not Recruiting
Location
Boston Medical Center
Start Date
2022-10-26
Trial ID
NCT05451771
The main aim is to show that long-term use of ixazomib can improve symptoms...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-06-30
Trial ID
NCT05183139
Treatments Being Tested
This study will independently assess the efficacy and safety of 11 combinat...
Status
Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2015-10
Trial ID
NCT02343042
The main aim of this study is to learn if ixazomib, given with dexamethason...
Status
Completed
Location
Highlands Oncology Group
Start Date
2017-08-01
Trial ID
NCT03170882
Treatments Being Tested
The purpose of this study is to determine the overall response rate of pati...
Status
Terminated
Location
UCSD Moores Cancer Center
Start Date
2018-10-17
Trial ID
NCT03590652